Showing results (91-100 of 143) with videos related to
Sort By:
Pageof 15
Antimicrobial Agents and Chemotherapy|October 24, 2007
Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilmsTimothy D Starner, Joshua D Shrout, Matthew R Parsek, et al.Antimicrobial Agents and Chemotherapy|May 13, 2009
Resistance selection studies comparing the activity of razupenem (PTZ601) to vancomycin and linezolid against eight methicillin-resistant and two methicillin-susceptible Staphylococcus aureus strainsCatherine Clark, Klaudia Kosowska-Shick, Pamela McGhee, et al.Antimicrobial Agents and Chemotherapy|November 26, 2008
In vitro activity of the quinolone WCK 771 against recent U.S. hospital and community-acquired Staphylococcus aureus pathogens with various resistance typesSachin S Bhagwat, Pamela McGhee, Klaudia Kosowska-Shick, et al.The Pediatric Infectious Disease Journal|September 14, 2004
Two dosages of clarithromycin for five days, amoxicillin/clavulanate for five days or penicillin V for ten days in acute group A streptococcal tonsillopharyngitisGeorge A Syrogiannopoulos, Bülent Bozdogan, Ioanna N Grivea, et al.Journal of the American Academy of Dermatology|September 27, 2003
White piedra: further evidence of a synergistic infectionSummer R Youker, Robert J Andreozzi, Peter C Appelbaum, et al.Antimicrobial Agents and Chemotherapy|December 26, 2001
Antipneumococcal activity of BMS 284756 compared to those of six other agentsGlenn A Pankuch, Kensuke Nagai, Todd A Davies, et al.Antimicrobial Agents and Chemotherapy|December 26, 2001
Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniaeAnnie Canu, Brigitte Malbruny, Maëlle Coquemont, et al.Antimicrobial Agents and Chemotherapy|September 19, 2007
Antistaphylococcal activity of CG400549, a new experimental FabI inhibitor, compared with that of other agentsTatiana Bogdanovich, Catherine Clark, Klaudia Kosowska-Shick, et al.Diagnostic Microbiology and Infectious Disease|August 24, 2010
Molecular and epidemiologic characteristics of linezolid-resistant coagulase-negative staphylococci at a tertiary care hospitalKlaudia Kosowska-Shick, Kathleen G Julian, Pamela L McGhee, et al.International Journal of Antimicrobial Agents|January 30, 2002
Comparative in vitro activity of gemifloxacin to other fluoroquinolones and non-quinolone agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the United States in 1999-2000Laura M Koeth, Michael R Jacobs, Saralee Bajaksouzian, et al.Pageof 15